Skip to main content
Top
Published in: Neurology and Therapy 2/2018

Open Access 01-12-2018 | Commentary

Patient and Physician Perspectives in a Case of Severe Traumatic Brain Injury

Author: Rhoderick M. Casis

Published in: Neurology and Therapy | Issue 2/2018

Login to get access

Abstract

Traumatic brain injury is a challenge for general practitioners and specialists worldwide due to the heterogeneous clinical picture, secondary injuries and complex treatment including surgery, medication, intensive care, nutrition and rehabilitation. This case report is about a TBI patient with a score of four on the Glasgow Coma Scale when she was transferred from the primary hospital to our center. Her condition, treatment options and expectations were discussed with the relatives. The patient was subjected to surgery and received pharmacologic intervention including a neurotrophic drug and extensive rehabilitation measures including occupational therapy. Considering the patient's remarkable recovery, a combination of multiple treatment approaches seems promising in patients with severe traumatic brain injury.
Literature
1.
go back to reference Theadom A, Feigin V, Reith F, Maas A. Epidemiology of traumatic brain injury. In: Winn HR, editor. Youmans and Winn neurological surgery. Philadelphia: Elsevier; 2017. Theadom A, Feigin V, Reith F, Maas A. Epidemiology of traumatic brain injury. In: Winn HR, editor. Youmans and Winn neurological surgery. Philadelphia: Elsevier; 2017.
2.
go back to reference Finkelstein E, Corso P, Miller T. The incidence and economic burden of injuries in the United States. New York: Oxford University Press; 2006.CrossRef Finkelstein E, Corso P, Miller T. The incidence and economic burden of injuries in the United States. New York: Oxford University Press; 2006.CrossRef
3.
go back to reference Wakai A, McCabe A, Roberts I, Schierhout G. Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev. 2013;8:CD001049. Wakai A, McCabe A, Roberts I, Schierhout G. Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev. 2013;8:CD001049.
4.
go back to reference Servadei F, Picetti E. Intracranial pressure monitoring and outcome in traumatic brain injury: the probe does matter? World Neurosurg. 2015;83:732–3.CrossRefPubMed Servadei F, Picetti E. Intracranial pressure monitoring and outcome in traumatic brain injury: the probe does matter? World Neurosurg. 2015;83:732–3.CrossRefPubMed
5.
go back to reference Christensen B, Colella B, Inness E, Hebert D, Monette G, Bayley M, Green RE. Recovery of cognitive function after traumatic brain injury: a multilevel modeling analysis of Canadian outcomes. Arch Phys Med Rehabil. 2008;89(12 Suppl 2):S3–15.CrossRefPubMed Christensen B, Colella B, Inness E, Hebert D, Monette G, Bayley M, Green RE. Recovery of cognitive function after traumatic brain injury: a multilevel modeling analysis of Canadian outcomes. Arch Phys Med Rehabil. 2008;89(12 Suppl 2):S3–15.CrossRefPubMed
6.
go back to reference Anderson J, Schmitter-Edgecombe M. Recovery of time estimation following moderate to severe traumatic brain injury. Neuropsychology. 2011;25(1):36–44.CrossRefPubMedPubMedCentral Anderson J, Schmitter-Edgecombe M. Recovery of time estimation following moderate to severe traumatic brain injury. Neuropsychology. 2011;25(1):36–44.CrossRefPubMedPubMedCentral
7.
go back to reference Powell J, Heslin J, Greenwood R. Community based rehabilitation after severe traumatic brain injury: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2002;72:193–202.CrossRefPubMedPubMedCentral Powell J, Heslin J, Greenwood R. Community based rehabilitation after severe traumatic brain injury: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2002;72:193–202.CrossRefPubMedPubMedCentral
8.
go back to reference Shakur H, Roberts I, Bautista R, CRASH-2 trial collaborators, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant hemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23–32.CrossRefPubMed Shakur H, Roberts I, Bautista R, CRASH-2 trial collaborators, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant hemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23–32.CrossRefPubMed
9.
go back to reference Olivecrona M, Koskinen LO. The IMPACT prognosis calculator used in patients with severe traumatic brain injury treated with an ICP-targeted therapy. Acta Neurochir (Wien). 2012;154:1567.CrossRef Olivecrona M, Koskinen LO. The IMPACT prognosis calculator used in patients with severe traumatic brain injury treated with an ICP-targeted therapy. Acta Neurochir (Wien). 2012;154:1567.CrossRef
10.
go back to reference Grigorakos L, Alexopoulou A, Tzortzopoulou K, Stratouli S, Chroni D. A predictors of outcome in patients with severe traumatic brain injury. J Neurosci Clin Res. 2016;1:1. Grigorakos L, Alexopoulou A, Tzortzopoulou K, Stratouli S, Chroni D. A predictors of outcome in patients with severe traumatic brain injury. J Neurosci Clin Res. 2016;1:1.
11.
go back to reference Martins ET, Linhares MN, Sousa DS, Schroeder HK, Meinerz J, et al. Mortality in severe traumatic brain injury: a multivariated analysis of 748 Brazilian patients from Florianópolis city. J Trauma. 2009;67(1):85–90.CrossRefPubMed Martins ET, Linhares MN, Sousa DS, Schroeder HK, Meinerz J, et al. Mortality in severe traumatic brain injury: a multivariated analysis of 748 Brazilian patients from Florianópolis city. J Trauma. 2009;67(1):85–90.CrossRefPubMed
12.
go back to reference McMillan TM, Teasdale GM, Weir CJ, Stewart E. Death after head injury: the 13-year outcome of a case control study. J Neurol Neurosurg Psychiatry. 2011;82:931.CrossRefPubMed McMillan TM, Teasdale GM, Weir CJ, Stewart E. Death after head injury: the 13-year outcome of a case control study. J Neurol Neurosurg Psychiatry. 2011;82:931.CrossRefPubMed
13.
go back to reference Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7:728.CrossRefPubMed Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7:728.CrossRefPubMed
14.
go back to reference Skolnick BE, Maas AI, Narayan RK, et al. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med. 2014;371:2457.CrossRef Skolnick BE, Maas AI, Narayan RK, et al. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med. 2014;371:2457.CrossRef
15.
16.
go back to reference Brain Trauma Foundation TBI Guidelines 2016. Guidelines for the management of severe traumatic brain injury, 4th ed. Neurosurgery 2016;3:p76. Brain Trauma Foundation TBI Guidelines 2016. Guidelines for the management of severe traumatic brain injury, 4th ed. Neurosurgery 2016;3:p76.
17.
go back to reference Giacino JT, Whyte J, et al. Placebo-controlled trial of amantadine for severe traumatic brain injury. N Engl J Med. 2012;366:819–26.CrossRefPubMed Giacino JT, Whyte J, et al. Placebo-controlled trial of amantadine for severe traumatic brain injury. N Engl J Med. 2012;366:819–26.CrossRefPubMed
18.
go back to reference Secades Julio. Citicoline for the treatment of head injury: a systematic review and meta-analysis of controlled clinical trials. J Trauma Treat. 2014;4:227.CrossRef Secades Julio. Citicoline for the treatment of head injury: a systematic review and meta-analysis of controlled clinical trials. J Trauma Treat. 2014;4:227.CrossRef
19.
go back to reference Zafronte RD, Bagiella E, Ansel BM, et al. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). JAMA. 2012;308:1993–2000.CrossRef Zafronte RD, Bagiella E, Ansel BM, et al. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). JAMA. 2012;308:1993–2000.CrossRef
20.
go back to reference Brain Trauma Foundation TBI Guidelines 2016. Guidelines for the management of severe traumatic brain injury, 4th ed. Neurosurgery 2016;0:3 Brain Trauma Foundation TBI Guidelines 2016. Guidelines for the management of severe traumatic brain injury, 4th ed. Neurosurgery 2016;0:3
21.
go back to reference He J, Fan J, Geng S. Efficacy of cerebrolysin in acute brain trauma. Chin J Clin Pract Med. 2002;4:71–2. He J, Fan J, Geng S. Efficacy of cerebrolysin in acute brain trauma. Chin J Clin Pract Med. 2002;4:71–2.
22.
go back to reference König P, Wannders R, Witzmann A, et al. Cerebrolysin in traumatic brain injury—a pilot study of a neurotrophic and neurogenic agent in the treatment of acute traumatic brain injury. J Neurol Neurochir Psychiatr. 2006;7:12–20. König P, Wannders R, Witzmann A, et al. Cerebrolysin in traumatic brain injury—a pilot study of a neurotrophic and neurogenic agent in the treatment of acute traumatic brain injury. J Neurol Neurochir Psychiatr. 2006;7:12–20.
23.
go back to reference El Sayed I, Zaki A, Fayed AM, Shehata GM, Abdelmonem S. A meta-analysis of the effect of different neuroprotective drugs in management of patients with traumatic brain injury. Neurosurg Rev. 2018;41:427–38.CrossRefPubMed El Sayed I, Zaki A, Fayed AM, Shehata GM, Abdelmonem S. A meta-analysis of the effect of different neuroprotective drugs in management of patients with traumatic brain injury. Neurosurg Rev. 2018;41:427–38.CrossRefPubMed
24.
go back to reference Muresanu DF, Heiss WD, Hoemberg V, et al. Cerebrolysin and recovery after stroke (CARS): a randomized, placebo-controlled, double-blind, multicenter trial. Stroke. 2016;47:151–9.CrossRefPubMed Muresanu DF, Heiss WD, Hoemberg V, et al. Cerebrolysin and recovery after stroke (CARS): a randomized, placebo-controlled, double-blind, multicenter trial. Stroke. 2016;47:151–9.CrossRefPubMed
Metadata
Title
Patient and Physician Perspectives in a Case of Severe Traumatic Brain Injury
Author
Rhoderick M. Casis
Publication date
01-12-2018
Publisher
Springer Healthcare
Published in
Neurology and Therapy / Issue 2/2018
Print ISSN: 2193-8253
Electronic ISSN: 2193-6536
DOI
https://doi.org/10.1007/s40120-018-0117-9

Other articles of this Issue 2/2018

Neurology and Therapy 2/2018 Go to the issue